AngioDynamics reported $-2.51M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Accuray USD 11.38M 12.71M Sep/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 4.35M 5.31M Sep/2026
Boston Scientific USD 1.01B 232M Sep/2026
Edwards Lifesciences USD 542.7M 23.2M Sep/2026
ICU Medical USD 58.59M 1.84M Sep/2026
J&J USD 6.47B 1B Sep/2026
Medtronic USD 1.84B 254M Jun/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Mesa Laboratories USD 4.45M 2.5M Sep/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Smiths GBP 200M 34M Dec/2026
Tandem Diabetes Care USD -2.37M 11.42M Sep/2026
Teleflex USD -105.77M 178.84M Sep/2026
Terumo JPY -18.68B 108.16B Sep/2026
Trinity Biotech USD -1.79M 481K Mar/2026